Fluoroquinoxalinone derivative for selectively inhibiting parp1
US-2025295642-A1 · Sep 25, 2025 · US
This page is not indexed by search engines while we improve data quality.
Dai Meibi patents
Dai Meibi is listed as an inventor on 9 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dai Meibi |
| Total patents | 9 |
| First publication | Jun 15, 2017 |
| Latest publication | Sep 25, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Pyridine derivative as fgfr and vegfr dual inhibitors
US-2022267324-A1 · Aug 25, 2022 · US
Pyrazolopyridine compound as ret inhibitor and application thereof
US-2022220104-A1 · Jul 14, 2022 · US
Azaindole derivative and use thereof as fgfr and c-met inhibitor
US-2021253571-A1 · Aug 19, 2021 · US
Quinoline derivative and use thereof as tyrosine kinase inhibitor
US-2020262791-A1 · Aug 20, 2020 · US
Vinyl compounds as FGFR and VEGFR inhibitors
US-10519133-B2 · Dec 31, 2019 · US
Vinyl compounds as fgfr and vegfr inhibitors
US-2018222886-A1 · Aug 9, 2018 · US
Antidiabetic substituted heteroaryl compounds
US-9834563-B2 · Dec 5, 2017 · US
Antidiabetic substituted heteroaryl compounds
US-2017166578-A1 · Jun 15, 2017 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Medshine Discovery Inc | 7 |
| Harbin Zhenbao Pharmaceutical Co Ltd | 2 |
| Merck Sharp & Dohme | 2 |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Baiyunshan Pharmaceutical General Factory | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 7 |
| C07D471/04 | 6 |
| C07D401/12 | 5 |
| A61K31/437 | 4 |
| C07D519/00 | 3 |